NCT07148414 - A Study of SPY072 in Rheumatic Disease | Biotech Hunter

Enrollment

285

Participants

Timeline

Start Date

August 21, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

March 31, 2028

Conditions

Rheumatoid ArthritisPsoriatic ArthritisAxial SpondyloarthritisRheumatic DiseasesRheumatic Joint DiseasePsA (Psoriatic Arthritis)AxSpARheumatologic Disease

Interventions

DRUG

SPY002-072

Experimental

DRUG

Placebo

Matching Placebo

Trial Locations (10)

16635

RECRUITING

Site 104, Duncansville

77375

RECRUITING

Site 103, Tomball

77377

RECRUITING

Site 102, Tomball

78404

RECRUITING

Site 105, Corpus Christi

90602

RECRUITING

Site 107, Whittier

91042

RECRUITING

Site 108, Tujunga

91722

RECRUITING

Site 111, Covina

91786

RECRUITING

Site 112, Upland

91910

RECRUITING

Site 114, Chula Vista

02446

RECRUITING

Site 101, Brookline

All Listed Sponsors

lead

Spyre Therapeutics, Inc.

INDUSTRY